Precise Biometrics AB's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 86.48.
Precise Biometrics AB's Days Inventory for the
three
months ended in Mar. 2026 was 4.14.
Precise Biometrics AB's Days Payable for the
three
months ended in Mar. 2026 was 45.8.
Therefore, Precise Biometrics AB's Cash Conversion Cycle (CCC) for the
three
months ended in Mar. 2026 was 44.82.
Precise Biometrics AB (OTCPK:PRBCF) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Precise Biometrics AB Cash Conversion Cycle Related Terms
Precise Biometrics AB Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Precise Biometrics AB's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PRBCF vs ALLE, MSA, ADT: Cash Conversion Cycle Comparison
For the Security & Protection Services subindustry, Precise Biometrics AB's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Precise Biometrics AB Cash Conversion Cycle vs Business Services Industry
For the Business Services industry and Industrials sector, Precise Biometrics AB's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Precise Biometrics AB's Cash Conversion Cycle falls into.
Precise Biometrics AB Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Precise Biometrics AB's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Precise Biometrics AB (PRBCF) has a Cash Conversion Cycle of 44.82 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Precise Biometrics AB and its competitors.
Is Precise Biometrics AB's Cash Conversion Cycle too high?
Precise Biometrics AB's current Cash Conversion Cycle is 44.82. The Business Services industry median Cash Conversion Cycle is 38.74. Precise Biometrics AB's value of 44.82 is 15.7% above this industry median. Overall, Precise Biometrics AB has a GF Score™ of 27/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Precise Biometrics AB's Cash Conversion Cycle compare to ALLE and MSA?
Precise Biometrics AB's Cash Conversion Cycle of 44.82 can be compared against companies in the Business Services industry. The industry median Cash Conversion Cycle is 38.74. Precise Biometrics AB's value of 44.82 is 15.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Business Services company?
The median Cash Conversion Cycle among Business Services companies is 38.74, based on 1,069 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Precise Biometrics AB's current Cash Conversion Cycle of 44.82 is 15.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Precise Biometrics AB and its competitors. For the Business Services industry, the median Cash Conversion Cycle is 38.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Precise Biometrics AB's current Cash Conversion Cycle is 44.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Precise Biometrics AB stock overvalued right now?
Based on GuruFocus' analysis, Precise Biometrics AB (PRBCF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.24, compared to a current price of $0.18 — trading 25% below its estimated fair value. The current Cash Conversion Cycle is 44.82 and 15.7% above the Business Services industry median of 38.74. Precise Biometrics AB's overall GF Score™ is 27/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Precise Biometrics AB (PRBCF), the current Cash Conversion Cycle is 44.82 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Precise Biometrics AB (PRBCF) Overvalued in 2026?
Based on GuruFocus' analysis, Precise Biometrics AB stock appears to be undervalued.
The current stock price of $0.18 is trading 25% below its estimated GF Value™ of $0.24.
GuruFocus considers Precise Biometrics AB to be Modestly Undervalued.
Key valuation signals for PRBCF:
Cash Conversion Cycle: 44.82
GF Value™: $0.24 vs. price of $0.18 (25% below fair value)
Industry Position: 15.7% above the Business Services median
No single metric tells the full story. See the PRBCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Precise Biometrics AB is engaged in the business of developing and selling identification software for the authentication of people's identity in mobile phones, laptops, smart cards, and products with sensors. The company has two product segments: Digital Identity and Biometric Technologies. In the Biometric Technologies segment which generates key revenue, the company licenses, among other things, its fingerprint software to sensor manufacturers and includes products like BioMatch, BioLive, and BioEnhance. The Digital Identity segment offers system solutions for visitor management and physical biometric access. The company provides premium solutions that enable secure and seamless access to data, mobile devices, premises, and trusted identities.
27GF Score
Get the complete analysis for PRBCF
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRBCF has been successfully added to your 
